Categories
Health

Third Covid shot could also be approach round masking, says Dr. Peter Hotez

Dr. Peter Hotez told CNBC that while the Centers for Disease Control and Prevention’s new Covid masking guidelines are “absolutely” necessary to battle the delta variant and surging cases, there might be an alternative to wearing masks indoors again. 

“There is potentially a way to get around it, and it may be that third immunization,” said Hotez, co-director of the Center for Vaccine Development at Texas Children’s Hospital.

The vaccines are currently proving to hold up against symptomatic illness and against serious illness, ICU admissions and hospitalizations. Hotez, however, noted that the vaccines “are not holding up as well” when it comes to stopping asymptomatic transmission, because the delta variant is so highly contagious. 

New data shows that people infected with the delta strain can carry up to 1,000 times more virus in their nasal passages than those infected with the original strain.

CDC Director Rochelle Walensky said Tuesday recent studies show that those vaccinated individuals who do become infected with Covid have just as much viral load as the unvaccinated, making it possible for them to spread the virus to others.

Hotez explained to “The News with Shepard Smith” that the booster shot could increase the virus- neutralizing antibodies in people who have been vaccinated, and that is important because it could help stop asymptomatic transmission. 

Categories
Health

They Waited, They Anxious, They Stalled. This Week, They Acquired the Shot.

CHICAGO – They admitted they could have shown up months ago. Many were content to finally do the right thing. Some grumbled that they had no other choice.

In a single day last week, more than half a million people in the United States flocked to high schools, pharmacies, and buses being converted into mobile clinics. Then they rolled up their sleeves and got their coronavirus vaccines.

These are the Americans who are being vaccinated at this moment of the pandemic: the reluctant, the fearful, the hesitant.

In dozens of interviews Thursday in eight states, at vaccination clinics, drug stores, and pop-up mobile sites, Americans who had finally arrived for their vaccinations offered a snapshot of a nation at a crossroads – facing a new surge in the virus but just slowly embrace the vaccines that might stop it.

The people who are being vaccinated now are not among the eager crowds that rushed to early appointments. But even they are not decidedly against vaccinations in the group.

Instead, they occupy a middle ground: they have been unwilling to get a coronavirus vaccine for months until something or someone – a stubborn family member, a job requirement, a growing sense that the shot was safe – convinced them otherwise.

How many people ultimately join this group and how quickly could determine the course of the coronavirus in the United States.

Some of the newly vaccinated said they made the decision abruptly, even casually, after months of inactivity. A woman in Portland, Oregon waited for an inducement before getting her syringe, and when she heard a pop-up clinic at a farmers market were giving out $ 150 gift certificates, she decided it was time . A 60-year-old man in Los Angeles came over spontaneously to be vaccinated when he noticed that, for once, there was no line in a clinic. One construction worker said his work schedule made it difficult to get the shot.

Many people said they arrived after strong pressure from family or friends for a vaccine.

“‘You’re going to die. Get the Covid vaccine,” Grace Carper, 15, recently told her mother, Nikki White of Urbandale, Iowa, as they discussed when they would get their vaccinations. Ms. White, 38, woke up on Thursday up and said she would. “If you want to get your vaccine, get up,” Ms. White said to her daughter, who was looking forward to the vaccination, and the couple went to a Hy-Vee supermarket together.

Others were moved by practical considerations: plans to attend college that required students to be vaccinated, a desire to hang out with high school classmates, or a job requiring unvaccinated staff to wear masks. Their responses suggest that mandates or increased restrictions on the unvaccinated, increasingly debated by employers and government officials, could make a significant difference.

Audrey Sliker, 18, of Southington, Connecticut, said she was given a chance because the New York governor announced that all students attending the State University of New York schools were required to do so. She plans to be a newbie at SUNY Cobleskill this fall.

“I just don’t like needles in general,” she said, walking out of a white tent that housed a mobile vaccination center in Middlefield, Conn. “So it’s more like, ‘Do I have to get them?'”

Many of the respondents described their decisions in personal, somewhat complicated terms.

Willie Pullen, 71, was nibbling on a bag of popcorn as he left a vaccination center in Chicago, one of the few people to show up that day. He wasn’t exactly against the vaccines. Almost everyone in his life was already vaccinated, he said, and although he was at greater risk because of his age, he believed he was healthy and strong enough to think about it for a while.

What drove him to a high school on the West Side of Chicago where free vaccines were being given was the illness of an aging friend’s mother. Mr. Pullen wanted to visit her. He felt it was irresponsible to do this without vaccination.

“I persevered,” said Mr. Pullen. “I had reservations about the safety of the vaccine and the government that is doing it. I just wanted to wait and see. “

The campaign to vaccinate Americans across the board against the coronavirus began with a roaring, high-energy surge earlier this year as millions of people were vaccinated every day and coveted vaccination dates were celebrated with happy selfies on social media. Efforts peaked on April 13 when an average of 3.38 million doses were administered in the United States. The Biden government aims to have 70 percent of American adults at least partially vaccinated by July 4th.

Updated

July 23, 2021, 10:06 p.m. ET

But the vaccinations have been falling steadily since mid-April and have remained on a plateau in the last few weeks. Weeks after the July 4th benchmark passed, effort has now decreased, distributing an average of about 537,000 doses per day – a decrease of about 84 percent from the high.

About 68.7 percent of American adults have received at least one injection. Conservative commentators and politicians have questioned the safety of the three vaccines the Food and Drug Administration has approved for emergency use, and in some parts of the country opposition to vaccination is politically linked. An analysis of the New York Times vaccine and voter records in each county of the United States found that both willingness to receive a coronavirus vaccine and actual vaccination rates in counties where a majority of residents voted to re-elect has, on average, Donald J. Trump votes lower.

Despite the delayed vaccination efforts, there are indications that alarming headlines about a new surge in coronavirus cases and the highly contagious Delta variant could lead more Americans to consider vaccination. On Friday, White House press secretary Jen Psaki said there had been “encouraging data” showing that the five states with the highest case numbers – Arkansas, Florida, Louisiana, Missouri and Nevada – also had higher vaccination rates.

In Florida, a Sarasota County clinic was quiet, a brightly lit waiting area full of mostly empty chairs. Several people came in, often no more than an hour or two in an hour. Lately they are vaccinating fewer than 30 people a day there.

Elysia Emanuele, 42, paralegal, came for an injection. One factor in her decision was the rising number of cases in the state, which she watched with concern.

“If everything went smoothly, if we’d shut down and do what we had to do and it was seemingly wiped out,” she said, “I think I probably would have gotten the vaccine less.”

In the shadow of a freeway underpass in South Los Angeles, volunteers and potential vaccinees attempted to chat over the roar of passing cars.

Ronald Gilbert, 60, said he doesn’t really believe in vaccines and has never been a fan of needles, but with an increase in cases he argued that “it is better to be on the safe side”.

Understand the state of vaccine mandates in the United States

“I feel better now if I do this seriously,” he said. “I’m going to run like a rooster, chest up, like, ‘Do you have the vaccine? I got the vaccine. ‘”

News of the Delta variant also changed the mind of Josue Lopez, 33, who hadn’t planned on getting a vaccine after his entire family tested positive for the coronavirus in December.

“I thought I was immune, but with this variant, if it’s more dangerous, it might not be enough,” he said. “Even now, I’m not sure it’s safe.”

At a vaccination site at Malcolm X College in Chicago, Sabina Richter, one of the workers there, said it used to be easy to find people to get injected. More recently, they had to offer incentives: passes to an amusement park in the northern suburbs and Lollapalooza.

“Some people come in and still hesitate,” she said. “We have to fight for each of them.”

Cherie Lockhart, an employee at a Milwaukee care facility for the elderly and disabled, said she was concerned about the vaccines because she didn’t trust a medical system she believed had always treated blacks differently.

She was not a vaccine opponent, she said, but just hesitated until she could be reassured. Her mother finally won her over.

“My mom has never steered me wrong,” said Ms. Lockhart, 35. “She said, ‘I feel like this is right in my heart.’ So I prayed about it. And finally I went with my guide light. “

Many of the people who checked for vaccinations said they wanted to see how the vaccines affected the Americans who were rushing to get them early.

“I know people who got it and they didn’t get sick, that’s why,” said Lisa Thomas, 45, a home nurse from Portland, Ore. “I haven’t heard of any case that anyone has been injured.” of it, and there is a lot to benefit from. “

For Cindy Adams, who works for a Des Moines insurance company, the requirement of her job, as an unvaccinated person, was wearing a mask that forced her to go to the Polk County Health Department’s driving clinic for her first dose of Pfizer BioNTech vaccine.

Ms. Adams, 52, said she was concerned about possible long-term effects of the vaccines. But now her husband, children, and most of her extended family have been vaccinated, as have most of their staff.

“I’m just sick of wearing the mask,” said Ms. Adams. “We had an event yesterday and I had to wear it for five hours because I was with a lot of people. And I was sick of it.

“Everyone else is healthy and hasn’t had any serious side effects, so I decided to join the crowd.”

Julie Bosman reported from Chicago. The coverage included Matt Craig from Los Angeles, Elizabeth Djinis from Sarasota, Florida, Timmy Facciola from Middlefield, Connecticut, Ann Hinga Klein from Des Moines, Emily Shetler from Portland, Oregon, and Dan Simmons from Milwaukee.

Categories
World News

Peter de Vries, Dutch Crime Reporter, Dies After Being Shot

AMSTERDAM — A Dutch crime reporter who was shot in the head in a brazen attack in central Amsterdam last week as he was leaving a television studio, died of his wounds on Thursday, his family said in a statement. The reporter, Peter R. de Vries, was 64.

“Peter has fought until the end, but has been unable to win this battle,” the statement, carried by the Dutch broadcast news service RTL Nieuws, said. “We are indescribably proud of him and at the same time inconsolable.”

Mr. de Vries, a well-known public figure in the Netherlands, was shot on the evening of July 6 by an unknown assailant. The attack led to broad condemnation in the country, where drug related crime and shootings have steadily increased over the last decade. European leaders have condemned the shooting, which raised questions about protections for journalists.

The police arrested two men last week in connection with the attack after stopping them in a car on a nearby highway. The police identified the suspects as a 35-year-old Polish citizen and a 21-year-old from Rotterdam. The police have said they believe the younger man was the gunman

Both suspects appeared in court in Amsterdam on Friday and they remain in custody.

Ferd Grapperhaus, the Dutch justice minister, called Mr. de Vries a “brave man” and said his death was “nothing less than a direct attack on our society.”

Mr. de Vries, who had hosted a televised crime show for nearly two decades and has long been known in the Netherlands for solving cold cases, had said he regularly received death threats.

The television show on which Mr. de Vries appeared before he was shot last week did not air last Friday, after threats from criminals who said they wanted to target the studio using automatic weapons or a rocket launcher, according to Dutch news media. The show has resumed its daily episodes, but will be recorded elsewhere, the network reported.

Mr. de Vries began his journalism career in 1978 at De Telegraaf, a popular Dutch newspaper. A decade later, he published a book on the kidnapping of the beer magnate Freddy Heineken. He covered many high-profile cases, including the 2005 disappearance of an Alabama teenager, Natalee Holloway, in Aruba, a Caribbean island that is part of the Netherlands; and a decades-long investigation into the rape and murder of an 11-year-old boy, Nicky Verstappen.

His television show, “Peter R. de Vries, Crime Reporter,” which began in 1995 and aired for 17 years, was his real breakthrough.

Most recently, Mr. de Vries had set up a foundation in the hopes of solving the 1993 disappearance of Tanja Groen, a young woman who vanished on her way home from a party. On Tuesday, Dutch public television aired a special program where viewers donated hundreds of thousands of euros to the cause.

Mr. de Vries, who was also the director of a law office, had been an adviser over the past year to a key witness in a trial over killings said to have been ordered by a criminal organization. The main defendant in the case, Ridouan Taghi, who is accused of leading the organization, was arrested in Dubai in 2019.

Derk Wiersum, a lawyer for the same key witness in that trial, was killed in Amsterdam in 2019. The witness’s brother was shot dead in 2018.

Amsterdam and other Dutch cities have been the scene of several shootings over the past decade in which criminals have targeted either each other or those interfering in their crimes. The nearby port of Rotterdam is one of the key gateways for importing cocaine into Europe, and the country is a leader in the illegal production of amphetamines and crystal meth.

Categories
Health

Dr. Kavita Patel says want for a Covid booster shot appears inevitable

Former Obama administration official Dr. Kavita Patel told CNBC on Monday that she expected a Covid vaccine booster to eventually be approved by U.S. regulators due to new, more transmissible variants of coronavirus.

“With the threat of the Delta variant and possibly other looming variants in the future, it seems inevitable that we will need a booster shot,” Patel said on Squawk Box. “But that trillion dollar question is when? It seems like six months is early.”

The comments from Patel, who now works as a family doctor in Washington, came before Pfizer representatives met with federal health officials on Monday to discuss the possible need for Covid booster vaccinations.

Pfizer recently said it is developing a booster shot to combat the highly transmissible Delta variant. In that announcement, the drug maker cited internal data and a study in Israel showing that six months after vaccination, people experience decreased immunity from Pfizer’s two-dose vaccine as Delta becomes the predominant variant in the country.

The company said a third dose of its existing vaccine could help boost immunity. Over the past few months, executives at Pfizer and its German partner BioNTech have said that people will likely need a third dose of vaccine within a year of being fully vaccinated.

However, shortly after Pfizer’s announcement last week, the Centers for Disease Control and Prevention and the Food and Drug Administration released a joint statement stating that fully vaccinated Americans do not currently need a booster vaccination.

This view is supported by health experts like Dr. Ashish Jha, dean of Brown University’s School of Public Health, shared. Jha told CNBC on Friday that he had “seen no evidence yet that anyone needs a third shot”.

While Patel said the data suggests that all three of the Covid vaccines currently approved in the US – the two-dose Pfizer and Moderna vaccines and the Johnson & Johnson single-dose vaccine – offer “more than enough immunity” To protect against severe hospitalization and death, Pfizer did not criticize Pfizer for working on the booster intake.

“I think what we do know is that, even six months ago, immunity declines over time. The question is, how long? ”Said Patel, who served as policy director for the Bureau of Interstate Affairs and Public Engagement in the Obama administration.

People shouldn’t get a third vaccination now, Patel warned.

“We have seen patients who did this accidentally or even deliberately, and they had even more dramatic side effects than the second shot, so I wouldn’t encourage anyone,” said Patel.

Finally, if a booster is recommended by regulators, people should expect the CDC to make recommendations for specific populations, similar to what happened when the vaccine was initially introduced with a focus on high-risk groups. “It won’t come one, it will all,” she said.

Patel said the conversation about booster shots in the US must take into account the global impact, given the difficult introduction in other parts of the world.

“It won’t help the United States if the rest of the world stays unvaccinated and they have the opportunity to get hundreds of millions of doses because we got a booster,” said Patel.

Categories
Health

U.S. Officers Push Again on Pfizer’s Request for Booster Shot Approval

Pfizer officials met privately with senior U.S. scientists and regulators on Monday to press for rapid approval of booster coronavirus vaccines amid growing public confusion over whether they are needed and opposition from federal health officials who say that the additional doses are now not required.

The high-level online meeting, which lasted an hour, and at which Pfizer’s chief scientist briefed virtually every top doctor in the federal government, took place the same day Israel began feeding heart transplant patients and others on the third dose of the Pfizer BioNTech vaccine administer weakened immune system. Officials said after the meeting that more data – and possibly several months – would be needed before regulators could determine whether booster injections were needed.

The two developments underscored the intensifying debate about whether booster injections are required in the US, when and for whom. Many American experts, including Dr. Anthony S. Fauci, President Biden’s senior medical advisor on the pandemic, have said there isn’t enough evidence yet that boosters are necessary. However, some say Israel’s move may anticipate a government decision to recommend it to at least the weak.

Pfizer is collecting information on antibody responses from those receiving a third dose, as well as data from Israel, and expects to share at least part of that in a formal application to the Food and Drug Administration for its coronavirus vaccine to expand its emergency clearance in the coming weeks.

However, the final decision on booster vaccination, several officials said after the meeting, will also depend on real-world information the Centers for Disease Control and Prevention has gathered about breakthrough infections – those that occur in people who have been vaccinated – who are serious or ill Cause hospital stays.

And any booster vaccination recommendations are likely to be calibrated within age groups as well, officials said. For example, if booster shots are recommended, they could first go to residents of nursing homes who received their vaccines in late 2020 or early 2021, while older people who received their first vaccinations in the spring may have to wait longer. And then the question arises, what kind of booster: a third dose of the original vaccine or perhaps a vaccination tailored to the highly contagious Delta variant, which is on the rise in the USA.

“It was an interesting meeting. They shared their data. There was nothing like a decision, ”said Dr. Fauci in a short interview Monday night, adding, “This is just part of a much bigger puzzle, and it’s part of the data, so there’s no question of a compelling case either way.”

Amy Rose, a Pfizer spokeswoman, said in a statement, “We had a productive meeting with US public health officials about elements of our research program and preliminary booster data.”

The Ministry of Health and Welfare, which convened the meeting, issued its own statement confirming the government’s stance. “At this point, fully vaccinated Americans don’t need a booster dose,” it said.

With less than half of the United States’ population being fully vaccinated, some experts said Monday the country must continue to focus on giving all Americans their first dose. The most important task of the Food and Drug Administration is to increase public confidence by granting full approval to the coronavirus vaccines used, which are initially approved in an emergency.

“At this point the most important strengthening we need is vaccinating people,” said Dr. Carlos del Rio, an infectious disease expert at Emory University in Atlanta. The booster doses in Israel, he added, “will help us answer some questions, but at the end of the day I disagree with what they are doing. I think it’s terribly premature. “

Within the Biden government, some fear that if Americans are convinced that coronavirus vaccines only offer short-lived immunity before needing a boost, they are less likely to accept vaccination. Those concerns could fall by the wayside, however, if new data from Israel, expected in the next few weeks, conclusively shows that immunity wears off after six to eight months, significantly increasing the risks for the elderly or other vulnerable populations.

The government convened the meeting on Monday in response to the announcement last week by Pfizer and its German partner BioNTech that they would develop a version of their vaccine targeting the Delta variant and reported promising results from studies with people who A third dose of the vaccine received original vaccine six months after the second.

The new dates Not yet published or peer-reviewed, but as announced by companies that they would submit data to the Food and Drug Administration to approve booster vaccinations surprised the Biden White House.

In an unusual joint statement Thursday evening, hours after Pfizer-BioNTech’s announcement, the FDA and CDC pushed back.

“Americans who are fully vaccinated currently do not need a booster,” the statement said, adding, “We are prepared for booster doses when and when science shows they are needed.”

The move can make economic sense for Pfizer-BioNTech. Since the outbreak of the pandemic, the partner companies have been following a “get to market first” strategy in the manufacture and marketing of their vaccines.

The companies did not accept federal funds or participate in Operation Warp Speed, former President Donald J. Trump’s fast-track vaccine initiative. Not only were they the first to get Food and Drug Administration approval for their coronavirus vaccine, the first to use the novel mRNA technology, but also the first to get their vaccine approved in adolescents.

The strategy has “paid off as well as you could wish,” said Steve Brozak, president of WBB Securities, a biotechnology-focused research investment bank.

Last week, Pfizer and BioNTech said a booster given six months after the second dose of the vaccine increased the effectiveness of antibodies against the original virus and beta variant by five to ten times. But antibody levels may not be the best biological measure of need for booster doses, say experts, who say it’s no surprise that antibodies increase after a third dose.

“The antibody response is not the only measure of immune protection,” said Dr. Leana S. Wen, a former health commissioner for Baltimore. “There have been several studies to suggest that these vaccines also stimulate B-cell and T-cell immunity. Even if there aren’t that many antibodies, it doesn’t mean someone isn’t protected. “

In Israel, the government has agreed to provide Pfizer with data on its vaccine recipients, and Pfizer has cross-checked the Israeli data with the results of its own laboratory tests. Some people familiar with the data say this suggests that those vaccinated may lose immunity after about six to eight months, leading to an increasing number of breakthrough infections.

The participants in Monday’s meeting were a who’s who of government doctors: Dr. Fauci; Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention; Dr. Francis Collins, the director of the National Institutes of Health; Dr. Vivek Murthy, the general surgeon; Dr. Rachel Levine, the assistant secretary of health; Dr. Janet Woodcock, acting FDA commissioner; Dr. Peter Marks, the director of the FDA’s Center for Biologics Evaluation and Research; and Dr. David Kessler, a former FDA commissioner who, among other things, leads the Biden government’s vaccine distribution efforts.

Dr. Del Rio, of Emory University, complained that the meeting was held privately on Monday instead of Pfizer publicly presenting its dates to the CDC’s Advisory Committee on Vaccine Practices, which will ultimately recommend whether booster injections are needed.

Just over two-thirds of American adults – 67.7 percent – got at least one Covid-19 shot, according to the CDC. The president had hoped to have at least partially vaccinated 70 percent of adults by July 4th.

Still, the national vaccination campaign has made it clear that the vaccine is successful in preventing disease, and studies suggest that vaccines against the Delta variant remain effective. Outbreaks occur in areas with low vaccination rates and the number of national cases has increased recently; according to a database from the New York Times.

World Health Organization officials on Monday stressed the importance of prioritizing global vaccine production and distribution over booster development, given the large gaps between countries’ vaccine programs.

“That doesn’t mean one or the other; it brings order to a crisis, ”said Dr. Michael Ryan, the organisation’s executive director of the emergency health program, on what the organization calls a two-stage pandemic.

Lauren McCarthy contributed to the coverage.

Categories
Health

No proof a booster shot is required, says Dr. Ashish Jha

Covid booster doses are currently not required, said the dean of the School of Public Health at Brown University on Friday, as highly transmissible new variants test the protection of available vaccines.

“Let me tell you where we are: the data is very clear, if you got your two shots from Moderna or Pfizer or a single shot from J&J you have a very high level of protection against all variants, including Delta” said Dr. Ashish Jha. “I haven’t seen any evidence yet that anyone needs a third shot.”

Jha’s comments come after Pfizer and BioNTech announced Thursday that they are developing a Covid-19 booster shot that will target the Delta variant. Company officials say another vaccination may be needed as immunity to the vaccine appears to decline over time.

In CNBC’s The News with Shepard Smith, Jha emphasized the importance of waiting for the dates when it comes to a booster shot.

“When this evidence comes along, and of course we will want to take that into account, I think I think it is unlikely that we will need third shots for most people,” Jha said.

The Centers for Disease Control and Prevention and the Food and Drug Administration issued a joint statement stating that Americans who are fully vaccinated do not need a booster vaccination.

“Americans who have been fully vaccinated currently do not need a booster vaccination. FDA, CDC, and [the National Institutes of Health] are involved in a science-based, rigorous process to check if or when a refresher might be needed, “said a joint statement released Thursday evening.

Categories
Health

Pfizer says it’s growing a Covid booster shot to focus on the extremely transmissible delta variant

Pfizer and BioNTech announced Thursday that they are developing a Covid-19 booster vaccine that will target the Delta variant amid concerns about the highly communicable strain that is already the predominant form of the disease in the United States.

The companies said that while they believe a third vaccination of their current two-dose vaccine has the potential to maintain the “highest level of protection” against all currently known variants, including Delta, they are “vigilant” and are developing an updated version of the Vaccine.

“As evidenced by real evidence from the Israeli Ministry of Health, the effectiveness of the vaccine has declined six months after vaccination, while at the same time the Delta variant is becoming the dominant variant in the country,” the companies said in a written statement.

“These results are consistent with an ongoing analysis of the companies’ Phase 3 study,” they said. “This is why we have said, and continue to believe, that all of the data we have, it is likely that a third dose may be required within 6 to 12 months of full vaccination.”

Clinical trials could begin as early as August, subject to regulatory approvals, the companies said.

The announcement comes on the same day the Olympic Games organizers said they would be banning all viewers from the Games this year after Japan declared a state of emergency designed to stem a wave of new Covid-19 infections that are partly due to the Delta variant is due.

Delta is estimated by the World Health Organization to be about 55% more transmissible than Alpha, the variant first found in the UK that once dominated the US, didn’t do as well at protecting against mild illnesses and the spread of the disease to others, scientists say.

On Monday, Israeli officials reported a decrease in the effectiveness of the Pfizer BioNTech vaccine in preventing infections and symptomatic diseases, but said it remained highly effective in preventing serious diseases.

In the US, health officials are urging all eligible Americans to get vaccinated as soon as possible, especially before the fall season when Delta is expected to lead to a further surge in new coronavirus cases, especially in places with the lowest vaccination rates.

There are about 1,000 counties in the U.S. with a Covid vaccination rate of less than 30%, mostly located in the Southeast and Midwest, said CDC Director Dr. Rochelle Walensky recently. In these areas, the authority already sees increasing infection rates due to the further spread of the delta variant.

Pfizer and BioNtech executives have repeatedly said that people will likely need a booster vaccination or a third dose within 12 months of full vaccination, as they expect vaccine-induced immunity to wear off over time. They also said that people are likely to have to take extra shots every year.

Pfizer and BioNTech are developing booster vaccines and are expected to apply for US approval for a third dose of their vaccine shortly.

Categories
Health

Putin reveals he had the Sputnik V shot as Russia struggles with Covid

Watching a live broadcast of the annual phone call of Russian President Vladimir Putin in the newsroom of the TASS news agency.

Gavriil Grigorov | TASS | Getty Images

Russian President Vladimir Putin on Wednesday said he received the Sputnik-V coronavirus vaccine as the Kremlin struggles to convince a skeptical public of the benefits of vaccination.

“I thought I needed to be protected as long as possible. So I decided to vaccinate with Sputnik V. The military is vaccinated with Sputnik V and after all I am the commander in chief, ”Putin said during his annual conference call where the public asked questions to the president.

“After the first shot, I didn’t feel anything. About four hours later there was some tenderness where I had the shot. I took the second.” [shot] at noon. I took my temperature at midnight. It was 37.2 [Celsius]. I went to sleep, woke up and my temperature was 36.6. That was it, “Putin said in a Reuters-translated commentary.

Putin had previously refused to say what Covid vaccine he received in March and the Kremlin said it would keep the information “a secret”. Putin was not filmed or photographed when he received the shot, leading to speculation among the Russian public and the international press that he had not received any Russian vaccine at all.

Doubts about Putin’s vaccination status have not helped allay Russians’ apparent reluctance to get a Covid vaccination, despite the incentives for older people to get the vaccination.

Russia has now approved four home-grown vaccines for use and was the first country in the world to approve a coronavirus vaccination, Sputnik V (its most famous vaccine), last August.

The fact that the vaccine was approved prior to the completion of clinical trials caused a stir in the global scientific community and is believed to have contributed to public skepticism about the vaccine’s safety and effectiveness.

Still, an interim analysis of the shot’s Phase 3 clinical trials, which included 20,000 participants and which were published in the peer-reviewed medical journal The Lancet in early February, found 91.6% of it against symptomatic Covid-19 infection was effective. Russia has tried to sell its vaccine to several countries around the world, especially its allies.

Still, vaccination rates at home remain very sluggish, much to the chagrin of Putin, who has extolled the benefits of Russian Covid vaccines and encouraged the public to take up vaccination. The vaccination rate is lagging behind many countries, including India, Mexico and Brazil.

Our World in Data figures show that 15% of the Russian population received one dose and 12% received their second dose.

Putin’s comments come as Russia struggles to contain Covid and the Delta variant in Moscow and St. Petersburg. Last Friday, the Russian coronavirus task force reported 20,393 new Covid cases, most of the cases confirmed in a single day since January 24, according to Reuters. 7,916 new infections were in Moscow. Russia has recorded nearly 5.5 million cases since the pandemic began.

During the question-and-answer session in front of various members of the public from across Russia, Putin raised a variety of issues including rising food prices, energy infrastructure, relations with Ukraine and housing issues. Over 1 million questions were put to Putin, the TASS news agency reported.

Regarding the mandatory vaccination of the population in light of the low vaccination rate, Putin reiterated on Wednesday that he still disagreed with it, despite steps being taken to get Russians to accept the vaccination with the prospect of restrictions and possible job losses those who do not accept it.

In Moscow, for example, officials said that 60% of workers in the service sector must have their first dose of a Covid vaccine before July 15.

Categories
Health

CDC says there’s seemingly hyperlink between uncommon coronary heart irritation in younger folks after Covid shot

A CDC safety group said there was a “likely link” between rare heart inflammation in adolescents and young adults, mostly after they received their second Covid-19 vaccine, citing the latest available data.

There have been more than 1,200 cases of myocarditis or pericarditis, mostly in those under 30 who have the Covid- Vaccine received from Pfizer or Moderna have practices methods exercises.

Myocarditis is the inflammation of the heart muscle while pericarditis is the inflammation of the membrane that surrounds the heart.

“The clinical picture of myocarditis cases after vaccination was variable and most often appeared within a week of the second dose, with chest pain being the most common,” said Dr. Grace Lee, Chair of the Committee’s Security Group. CDC officials are collecting more data to fully understand the potential risks, how to deal with them and if there are any long-term issues, she said.

Zoom In Icon Arrows pointing outwards

The agency said 267 cases of myocarditis or pericarditis were reported after receiving one dose of the mRNA vaccines and 827 cases after two doses by June 11. There are 132 additional cases where the number of doses received is unknown, the CDC said.

The agency announced that around 300 million shots had been administered by June 11.

“This is still a rare occurrence,” said Dr. Tom Shimabukuro at the meeting. For both vaccines combined, there were 12.6 cases of heart inflammation per million doses. Cases were more common among Moderna vaccine recipients at 19.8 cases per million than eight cases per million at Pfizer, he said.

Men under 30 make up the bulk of cases, the CDC said, and most cases appear to be mild. Of the 295 people who developed the disease and were discharged, 79% made a full recovery, according to the presentation. Nine people were hospitalized, according to the agency, two of them in the intensive care unit.

CDC officials said the benefits of the Covid vaccine still outweigh the risks.

Cases in younger people are increasing as older people are vaccinated at higher rates. The US vaccinated 177.6 million people with at least one dose, according to the CDC, that’s about 53% of the population. Only 13.6% of 18- to 24-year-olds in the United States received at least one dose of vaccine, compared with 26% of people ages 50 to 64, the data shows.

While hospitalization rates have decreased in older age groups, they have barely moved in adolescents and young adults, said Dr. Megan Wallace from the CDC.

“Teenagers and young adults make up a larger proportion of the total cases, 33% of the cases reported in May were people ages 12-29, compared with 28% last December,” she said. Since the pandemic began, 2,767 people aged 12 to 29 have died of Covid, she said, noting that 316 of these deaths had occurred since April 1.

The CDC is coordinating its investigation with the Food and Drug Administration, which last month approved the Pfizer BioNTech vaccine for adolescents ages 12-15. Symptoms like chest pain and shortness of breath usually develop within a week of receiving the vaccination, with most developing within four days, the agency said.

This is a developing story. Please check again for updates.

CNBC’s Rich Mendez contributed to this article.

Correction: Most of the cases of people who had myocarditis occurred in people under the age of 30. In a previous version, the age was incorrectly stated. The number of cases per million doses administered was 12.6. In an earlier version, the number was incorrectly specified.

Categories
Health

New York carry most Covid restrictions with 70% of adults vaccinated with one shot

Masked people walk Times Square in New York City on May 19, 2021.

John Smith | Corbis News | Getty Images

New York will lift most of its Covid-19 restrictions now that 70% of all adults in the state have been vaccinated with at least one dose, Governor Andrew Cuomo announced on Tuesday.

Cuomo said all government-imposed restrictions on commercial businesses, social facilities, sports and recreational events, construction, manufacturing and retail introduced since March 2020 will be lifted “with immediate effect.”

“We can live again. Shops can open because government mandates are gone, restrictions on social gatherings, capacity restrictions, health checks, cleaning and disinfection protocols, “he said. “Think about June 15th. Think about today because it is the day New York was resurrected.”

Residents and visitors are still required to wear masks in some settings such as hospitals, public transportation and schools according to guidelines recommended by the Centers for Disease Control and Prevention, he said, but all other state-mandated Covid restrictions will be lifted across New York. The state will allow schools and camps to decide whether masks are required for children during outdoor activities.

While New York, which was an early epicenter of the global outbreak last March and April, recorded more than 2 million cases and nearly 53,000 Covid deaths, it now has one of the lowest rates of positivity in the United States.

On Sunday, the state’s seven-day positivity rate was 0.41%, up from a high of 7.9% on Jan. 4. Every region of the state has a positivity rate of less than 1%.

Cuomo emphasized that 70% is a great milestone and a sign that the state is fine, but it’s not the finish line. “We want to celebrate, but we want to remember what we are celebrating,” said Cuomo on Monday. “We come around the last corner.”

More than 11.1 million residents of the state have been vaccinated with at least one vaccination, and about 9.8 million are fully vaccinated, according to the state.

The state has administered more shots per capita than any other large state in the country, according to the CDC.

New York suffered widespread closings of its bars and restaurants due to pandemic lockdowns. Many restaurants and bars in New York City did not survive. The restaurant industry employs nearly 1 million people in the state, which is 9% of total employment in the state.

Before the pandemic, the unemployment rate in New York state was 3.9%. That number skyrocketed to 16.2% during the worst of the pandemic in April 2020. About a year later, the unemployment rate was 8.2% in April.

Cuomo said the state will lift capacity restrictions, social distancing, hygiene protocols, health exams, some contact tracing, and more.

President Joe Biden’s goal is to have 70% of adults in the United States vaccinated with at least one vaccine by July 4th.

The Empire State Building and all other state assets will glow blue and gold to celebrate the milestone vaccination rate.